BackSotera Health Overview
Sotera Health Co

Sotera Health Target Price

Analysts' average 12-month price target for Sotera Health is $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$18.9

Average Target Price

$19.503.2% upside

2 analysts in the last 4 months

High: $20 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-24UBS$190.5% upsideOpen
2026-06-05Goldman SachsEvie Koslosky$205.8% upsideOpen
2026-04-14Barclays$184.8% downsideOpen
2026-01-09Piper SandlerJason Bednar$2427% upsideOpen
2026-01-08RBC CapitalRyan Halstead$2427% upsideOpen
2025-11-05Piper Sandler$1710.1% downsideOpen
2025-11-05Barclays$205.8% upsideOpen
2025-10-02Barclays$190.5% upsideOpen
2025-05-05Goldman SachsMatthew Sykes$1710.1% downsideOpen
2024-12-05JefferiesDavid Windley$1520.6% downsideOpen
2024-11-06JefferiesDavid Windley$184.8% downsideOpen
2024-08-06BarclaysLuke Sergott$1710.1% downsideOpen
2024-06-06JefferiesDavid Windley$14.523.3% downsideOpen
2024-05-21Piper SandlerJason Bednar$1331.2% downsideOpen
2024-05-03RBC CapitalSean Dodge$1710.1% downsideOpen
2024-04-10BarclaysLuke Sergott$1425.9% downsideOpen
2024-03-25JefferiesDavid Windley$15.518% downsideOpen
2023-06-26Loop Capital MarketsMatthew Mishan$2427% upsideOpen
2023-01-10Wolfe ResearchMike Polark$2532.3% upsideOpen
2023-01-10BarclaysLuke Sergott$2216.4% upsideOpen
2022-11-23Goldman Sachs$857.7% downsideOpen
2022-11-15Barclays$668.3% downsideOpen

Sotera Health (SHC) FAQ

Sotera Health's target price stands at $20. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $20 for SHC implies 3.2% upside versus today's price ($18.9). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Sotera Health's target price evolved across reporting periods, while the comparison chart places SHC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Sotera Health's reading of $20 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.